MTND2P38

Across TCGA pan-cancer cohorts, MTND2P38 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated MTND2P38 data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher MTND2P38 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTND2P38 expression acts as an unfavorable survival marker, although some lineages such as GBM and LAML show a favorable association.

ESCA, ACC, and SARC are the cancer types where MTND2P38 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Tertile	All	0.406	0.953	.002	63	view →
ACC	DFS	Tertile	All	0.046	0.753	<.001	54	view →
SARC	DFS	Tertile	All	0.137	0.635	.002	24	view →
UCEC	DFS	Tertile	IV	0.292	0.717	.030	18	view →
PRAD	OS	Tertile	All	0.921	0.996	.006	12	view →
SKCM	DFS	Tertile	IV	0.016	0.541	.008	9	view →
CHOL	OS	Tertile	All	0.155	0.725	.029	9	view →
GBM	DFS	Tertile	All	0.689	0.202	.042	6	view →
STAD	DFS	Quartile	III,IV	0.418	0.651	.033	3	view →
LAML	DFS	Tertile	All	0.695	0.469	.044	2	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

MTND2P38–ESCA (OS)

Open the ESCA breakdown →